Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
J. European Academy of Dermatology and Venereology, 4 August 2014
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
PLOS ONE | https://doi.org/10.1371/journal.pone.0186835 October 30, 2017
PLOS ONE | https://doi.org/10.1371/journal.pone.0210937
February 5, 2019
PLOS ONE | https://doi.org/10.1371/journal.pone.0196239 April 23, 2018
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...duce HIV-related morbidity and mortality. Further, co-trimoxazole is an off-patent drug and widely available in resource-limited settings.
more
Compendium of Case Studies